COMBINED VACCINE AGAINST ANTHRAX IN ANIMALS
FIELD: veterinary biology and immunology. SUBSTANCE: the present innovation deals with manufacturing and application of biological preparations for vaccination in animals. The suggested vaccine includes protective antigen of vaccine strain 55 VNIIVV&M at concentration of 17,5±2,5 immunizing dose...
Saved in:
Main Authors | , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Russian |
Published |
10.01.2004
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | FIELD: veterinary biology and immunology. SUBSTANCE: the present innovation deals with manufacturing and application of biological preparations for vaccination in animals. The suggested vaccine includes protective antigen of vaccine strain 55 VNIIVV&M at concentration of 17,5±2,5 immunizing doses and alive spores of vaccine strain STI-1 at concentration of 2,5±0,3.107/ml physiological solution. This vaccine is safe and provides tense antitoxic and antimicrobial immunity against anthrax. This innovation could be applied for specific prophylaxis of anthrax in animals. EFFECT: higher efficiency. 6 tbl |
---|---|
Bibliography: | Application Number: RU20010135034 |